-
1
-
-
0344442746
-
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
-
Janzen N.K., Kim H.L., Figlin R.A., and Belldegrun A.S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am. 30 (2003) 843-852
-
(2003)
Urol. Clin. North Am.
, vol.30
, pp. 843-852
-
-
Janzen, N.K.1
Kim, H.L.2
Figlin, R.A.3
Belldegrun, A.S.4
-
3
-
-
29044438856
-
Interferon-α 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study
-
Bex A., Kerst M., Mallo H., Meinhardt W., Horenblas S., and de Gast G.C. Interferon-α 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study. Eur. Urol. 49 (2006) 76-81
-
(2006)
Eur. Urol.
, vol.49
, pp. 76-81
-
-
Bex, A.1
Kerst, M.2
Mallo, H.3
Meinhardt, W.4
Horenblas, S.5
de Gast, G.C.6
-
4
-
-
0036304007
-
Chemoprevention of bladder cancer
-
Kamat A.M., and Lamm D.L. Chemoprevention of bladder cancer. Urol. Clin. North Am. 29 (2002) 157-168
-
(2002)
Urol. Clin. North Am.
, vol.29
, pp. 157-168
-
-
Kamat, A.M.1
Lamm, D.L.2
-
5
-
-
0142166328
-
Cancer chemoprevention with dietary phytochemicals
-
Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003) 768-780
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 768-780
-
-
Surh, Y.J.1
-
6
-
-
0036670787
-
Flavonoid antioxidant silymarin and skin cancer
-
Singh R.P., and Agarwal R. Flavonoid antioxidant silymarin and skin cancer. Antioxid. Redox Signal. 4 (2002) 655-663
-
(2002)
Antioxid. Redox Signal.
, vol.4
, pp. 655-663
-
-
Singh, R.P.1
Agarwal, R.2
-
7
-
-
0034859659
-
Silymarin: a review of its clinical properties in the management of hepatic disorders
-
Wellington K., and Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. Biodrugs 15 (2001) 465-489
-
(2001)
Biodrugs
, vol.15
, pp. 465-489
-
-
Wellington, K.1
Jarvis, B.2
-
8
-
-
0036606413
-
Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels
-
Singh R.P., Dhanalakshmi S., Tyagi A.K., Chan D.C., Agarwal C., and Agarwal R. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. Cancer Res. 62 (2002) 3063-3069
-
(2002)
Cancer Res.
, vol.62
, pp. 3063-3069
-
-
Singh, R.P.1
Dhanalakshmi, S.2
Tyagi, A.K.3
Chan, D.C.4
Agarwal, C.5
Agarwal, R.6
-
9
-
-
0030903321
-
Protective effects of silymarin against photocarcinogenesis in a mouse skin model
-
Katiyar S.K., Korman N.J., Mukhtar H., and Agarwal R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl. Cancer Inst. 89 (1997) 556-566
-
(1997)
J. Natl. Cancer Inst.
, vol.89
, pp. 556-566
-
-
Katiyar, S.K.1
Korman, N.J.2
Mukhtar, H.3
Agarwal, R.4
-
10
-
-
0037057520
-
Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats
-
Kohno H., Tanaka T., Kawabata K., Hirose Y., Sugie S., Tsuda H., and Mori H. Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int. J. Cancer 101 (2002) 461-468
-
(2002)
Int. J. Cancer
, vol.101
, pp. 461-468
-
-
Kohno, H.1
Tanaka, T.2
Kawabata, K.3
Hirose, Y.4
Sugie, S.5
Tsuda, H.6
Mori, H.7
-
11
-
-
0344827261
-
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells
-
Agarwal C., Singh R.P., Dhanalakshmi S., Tyagi A.K., Tecklenburg M., Sclafani R.A., and Agarwal R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22 (2003) 8271-8282
-
(2003)
Oncogene
, vol.22
, pp. 8271-8282
-
-
Agarwal, C.1
Singh, R.P.2
Dhanalakshmi, S.3
Tyagi, A.K.4
Tecklenburg, M.5
Sclafani, R.A.6
Agarwal, R.7
-
12
-
-
33746127995
-
Molecular targeting therapy for renal cell carcinoma
-
Eto M., and Naito S. Molecular targeting therapy for renal cell carcinoma. Int. J. Clin. Oncol. 11 (2006) 209-213
-
(2006)
Int. J. Clin. Oncol.
, vol.11
, pp. 209-213
-
-
Eto, M.1
Naito, S.2
-
13
-
-
33750711391
-
Kinase inhibitors in the treatment of renal cell carcinoma
-
Larkin J.M., and Eisen T. Kinase inhibitors in the treatment of renal cell carcinoma. Crit. Rev. Oncol. Hematol. 60 (2006) 216-226
-
(2006)
Crit. Rev. Oncol. Hematol.
, vol.60
, pp. 216-226
-
-
Larkin, J.M.1
Eisen, T.2
-
14
-
-
26944435502
-
Targeted agents for the treatment of advanced renal cell carcinoma
-
Staehler M., Rohrmann K., Haseke N., Stief C.G., and Siebels M. Targeted agents for the treatment of advanced renal cell carcinoma. Curr. Drug Targets 6 (2005) 835-846
-
(2005)
Curr. Drug Targets
, vol.6
, pp. 835-846
-
-
Staehler, M.1
Rohrmann, K.2
Haseke, N.3
Stief, C.G.4
Siebels, M.5
-
15
-
-
34249909820
-
The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation
-
Cohen D., Lane B., Jin T., Magi-Galluzzi C., Finke J., Rini B.I., Bukowski R.M., and Zhou M. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation. Clin. Genitourin. Cancer 5 (2007) 264-270
-
(2007)
Clin. Genitourin. Cancer
, vol.5
, pp. 264-270
-
-
Cohen, D.1
Lane, B.2
Jin, T.3
Magi-Galluzzi, C.4
Finke, J.5
Rini, B.I.6
Bukowski, R.M.7
Zhou, M.8
-
16
-
-
34247156342
-
EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer
-
Badalian G., Derecskei K., Szendroi A., Szendroi M., and Timar J. EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer. Anticancer Res. 27 (2007) 889-894
-
(2007)
Anticancer Res.
, vol.27
, pp. 889-894
-
-
Badalian, G.1
Derecskei, K.2
Szendroi, A.3
Szendroi, M.4
Timar, J.5
-
18
-
-
28244442462
-
Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease
-
Fadeel B., and Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 258 (2005) 479-517
-
(2005)
J. Intern. Med.
, vol.258
, pp. 479-517
-
-
Fadeel, B.1
Orrenius, S.2
-
19
-
-
33749550856
-
Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells
-
Lee T.J., Kim E.J., Kim S., Jung E.M., Park J.W., Jeong S.H., Park S.E., Yoo Y.H., and Kwon T.K. Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol. Cancer Ther. 5 (2006) 2398-2407
-
(2006)
Mol. Cancer Ther.
, vol.5
, pp. 2398-2407
-
-
Lee, T.J.1
Kim, E.J.2
Kim, S.3
Jung, E.M.4
Park, J.W.5
Jeong, S.H.6
Park, S.E.7
Yoo, Y.H.8
Kwon, T.K.9
-
20
-
-
14544282903
-
Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer
-
Srinivasan R., and Linehan W.M. Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer. J. Clin. Oncol. 23 (2005) 410-412
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 410-412
-
-
Srinivasan, R.1
Linehan, W.M.2
-
21
-
-
16544375170
-
Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by l-buthionine sulfoximine
-
Wu X.X., Ogawa O., and Kakehi Y. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by l-buthionine sulfoximine. Int. J. Oncol. 24 (2004) 1489-1497
-
(2004)
Int. J. Oncol.
, vol.24
, pp. 1489-1497
-
-
Wu, X.X.1
Ogawa, O.2
Kakehi, Y.3
-
22
-
-
33745112128
-
Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-κB in mouse epidermal JB6 cells
-
Singh R.P., Dhanalakshmi S., Mohan S., Agarwal C., and Agarwal R. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-κB in mouse epidermal JB6 cells. Mol. Cancer Ther. 5 (2006) 1145-1153
-
(2006)
Mol. Cancer Ther.
, vol.5
, pp. 1145-1153
-
-
Singh, R.P.1
Dhanalakshmi, S.2
Mohan, S.3
Agarwal, C.4
Agarwal, R.5
-
23
-
-
0034057320
-
Apoptosis in cancer
-
Lowe S.W., and Lin A.W. Apoptosis in cancer. Carcinogenesis 21 (2000) 485-495
-
(2000)
Carcinogenesis
, vol.21
, pp. 485-495
-
-
Lowe, S.W.1
Lin, A.W.2
-
24
-
-
0037267333
-
Validating survivin as a cancer therapeutic target
-
Altieri D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3 (2003) 46-54
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 46-54
-
-
Altieri, D.C.1
-
25
-
-
11344256534
-
Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects
-
Li G., Lambert C., Gentil-Perret A., Genin C., and Tostain J. Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects. Prog. Urol. 13 (2003) 1-13
-
(2003)
Prog. Urol.
, vol.13
, pp. 1-13
-
-
Li, G.1
Lambert, C.2
Gentil-Perret, A.3
Genin, C.4
Tostain, J.5
-
26
-
-
0034667455
-
Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells
-
Zi X., Zhang J., Agarwal R., and Pollak M. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res. 60 (2000) 5617-5620
-
(2000)
Cancer Res.
, vol.60
, pp. 5617-5620
-
-
Zi, X.1
Zhang, J.2
Agarwal, R.3
Pollak, M.4
-
27
-
-
0347121831
-
Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line
-
Qi L., Singh R.P., Lu Y., Agarwal R., Harrison G.S., Franzusoff A., and Glode L.M. Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line. Cancer Biol. Ther. 2 (2003) 526-531
-
(2003)
Cancer Biol. Ther.
, vol.2
, pp. 526-531
-
-
Qi, L.1
Singh, R.P.2
Lu, Y.3
Agarwal, R.4
Harrison, G.S.5
Franzusoff, A.6
Glode, L.M.7
-
28
-
-
4544287556
-
Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages
-
Tyagi A., Agarwal C., Harrison G., Glode L.M., and Agarwal R. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis 25 (2004) 1711-1720
-
(2004)
Carcinogenesis
, vol.25
, pp. 1711-1720
-
-
Tyagi, A.1
Agarwal, C.2
Harrison, G.3
Glode, L.M.4
Agarwal, R.5
-
29
-
-
0344495296
-
Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells
-
Tyagi A.K., Agarwal C., Singh R.P., Shroyer K.R., Glode L.M., and Agarwal R. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Biochem. Biophys. Res. Commun. 312 (2003) 1178-1184
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.312
, pp. 1178-1184
-
-
Tyagi, A.K.1
Agarwal, C.2
Singh, R.P.3
Shroyer, K.R.4
Glode, L.M.5
Agarwal, R.6
-
30
-
-
33745002041
-
Prostate cancer chemoprevention by silibinin: bench to bedside
-
Singh R.P., and Agarwal R. Prostate cancer chemoprevention by silibinin: bench to bedside. Mol. Carcinog. 45 (2006) 436-442
-
(2006)
Mol. Carcinog.
, vol.45
, pp. 436-442
-
-
Singh, R.P.1
Agarwal, R.2
-
31
-
-
33744824356
-
Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway
-
Chen P.N., Hsieh Y.S., Chiang C.L., Chiou H.L., Yang S.F., and Chu S.C. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J. Dent. Res. 85 (2006) 220-225
-
(2006)
J. Dent. Res.
, vol.85
, pp. 220-225
-
-
Chen, P.N.1
Hsieh, Y.S.2
Chiang, C.L.3
Chiou, H.L.4
Yang, S.F.5
Chu, S.C.6
-
32
-
-
26044455880
-
Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways
-
Chen P.N., Hsieh Y.S., Chiou H.L., and Chu S.C. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem. Biol. Interact. 156 (2005) 141-150
-
(2005)
Chem. Biol. Interact.
, vol.156
, pp. 141-150
-
-
Chen, P.N.1
Hsieh, Y.S.2
Chiou, H.L.3
Chu, S.C.4
-
33
-
-
2942672061
-
Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells
-
Mohan S., Dhanalakshmi S., Mallikarjuna G.U., Singh R.P., and Agarwal R. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun. 320 (2004) 183-189
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.320
, pp. 183-189
-
-
Mohan, S.1
Dhanalakshmi, S.2
Mallikarjuna, G.U.3
Singh, R.P.4
Agarwal, R.5
-
34
-
-
0036210452
-
Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis
-
Singh R.P., Tyagi A.K., Zhao J., and Agarwal R. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis 23 (2002) 499-510
-
(2002)
Carcinogenesis
, vol.23
, pp. 499-510
-
-
Singh, R.P.1
Tyagi, A.K.2
Zhao, J.3
Agarwal, R.4
-
35
-
-
11144222544
-
Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor κB-mediated inducible chemoresistance
-
Singh R.P., Mallikarjuna G.U., Sharma G., Dhanalakshmi S., Tyagi A.K., Chan D.C., Agarwal C., and Agarwal R. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor κB-mediated inducible chemoresistance. Clin. Cancer Res. 10 (2004) 8641-8647
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 8641-8647
-
-
Singh, R.P.1
Mallikarjuna, G.U.2
Sharma, G.3
Dhanalakshmi, S.4
Tyagi, A.K.5
Chan, D.C.6
Agarwal, C.7
Agarwal, R.8
-
36
-
-
33846211547
-
Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3
-
Cheung C.W., Vesey D.A., Nicol D.L., and Johnson D.W. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3. BJU Int. 99 (2007) 454-460
-
(2007)
BJU Int.
, vol.99
, pp. 454-460
-
-
Cheung, C.W.1
Vesey, D.A.2
Nicol, D.L.3
Johnson, D.W.4
-
37
-
-
34447130474
-
Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels
-
Cheung C.W., Taylor P.J., Kirkpatrick C.M., Vesey D.A., Gobe G.C., Winterford C., Nicol D.L., and Johnson D.W. Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels. BJU Int. 100 (2007) 438-444
-
(2007)
BJU Int.
, vol.100
, pp. 438-444
-
-
Cheung, C.W.1
Taylor, P.J.2
Kirkpatrick, C.M.3
Vesey, D.A.4
Gobe, G.C.5
Winterford, C.6
Nicol, D.L.7
Johnson, D.W.8
-
38
-
-
27644439523
-
Mechanisms and preclinical efficacy of silibinin in preventing skin cancer
-
Singh R.P., and Agarwal R. Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur. J. Cancer 41 (2005) 1969-1979
-
(2005)
Eur. J. Cancer
, vol.41
, pp. 1969-1979
-
-
Singh, R.P.1
Agarwal, R.2
-
39
-
-
0033571983
-
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties
-
Mahotka C., Wenzel M., Springer E., Gabbert H.E., and Gerharz C.D. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 59 (1999) 6097-6102
-
(1999)
Cancer Res.
, vol.59
, pp. 6097-6102
-
-
Mahotka, C.1
Wenzel, M.2
Springer, E.3
Gabbert, H.E.4
Gerharz, C.D.5
-
40
-
-
34548309081
-
Prognostic markers in renal cell carcinoma
-
Ljungberg B. Prognostic markers in renal cell carcinoma. Curr. Opin. Urol. 17 (2007) 303-308
-
(2007)
Curr. Opin. Urol.
, vol.17
, pp. 303-308
-
-
Ljungberg, B.1
-
41
-
-
34250209885
-
Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma
-
Krambeck A.E., Dong H., Thompson R.H., Kuntz S.M., Lohse C.M., Leibovich B.C., Blute M.L., Sebo T.J., Cheville J.C., Parker A.S., and Kwon E.D. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clin. Cancer Res. 13 (2007) 1749-1756
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 1749-1756
-
-
Krambeck, A.E.1
Dong, H.2
Thompson, R.H.3
Kuntz, S.M.4
Lohse, C.M.5
Leibovich, B.C.6
Blute, M.L.7
Sebo, T.J.8
Cheville, J.C.9
Parker, A.S.10
Kwon, E.D.11
-
42
-
-
33846519318
-
Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome
-
Byun S.S., Yeo W.G., Lee S.E., and Lee E. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome. Urology 69 (2007) 34-37
-
(2007)
Urology
, vol.69
, pp. 34-37
-
-
Byun, S.S.1
Yeo, W.G.2
Lee, S.E.3
Lee, E.4
-
43
-
-
34249863881
-
Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy
-
Comelli M.C., Mengs U., Schneider C., and Prosdocimi M. Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy. Integr. Cancer Ther. 6 (2007) 120-129
-
(2007)
Integr. Cancer Ther.
, vol.6
, pp. 120-129
-
-
Comelli, M.C.1
Mengs, U.2
Schneider, C.3
Prosdocimi, M.4
-
44
-
-
34547829030
-
Silibinin inhibits constitutive activation of Stat3 and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells
-
Agarwal C., Tyagi A., Kaur M., and Agarwal R. Silibinin inhibits constitutive activation of Stat3 and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis 28 (2007) 1463-1470
-
(2007)
Carcinogenesis
, vol.28
, pp. 1463-1470
-
-
Agarwal, C.1
Tyagi, A.2
Kaur, M.3
Agarwal, R.4
|